Market cap of T2 Biosystems Inc. [TTOO] reaches 31.50M – now what?

T2 Biosystems Inc. [NASDAQ: TTOO] price surged by 18.57 percent to reach at $0.02. The company report on September 22, 2022 that T2 Biosystems Announces Commercial Expansion Through Distributor in Baltic Region.


China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored


T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia. Under the terms of the agreement, T2 Biosystems will sell T2Dx® Instruments, along with T2Bacteria®, T2Candida® and T2Resistance® Panels through the distributor.

The execution of this exclusive distribution agreement further expands T2 Biosystems’ commercialization. Epidemiology studies have shown that the Baltic region has a higher average incidence of sepsis per population than Western Europe.1 There have been national guidelines in the region to address the impact of sepsis.2 The introduction of the T2Dx Instrument and sepsis panels into these countries will allow rapid detection of sepsis-causing pathogens and antibiotic resistance genes, in hours instead of days, enabling clinicians to achieve targeted therapy, faster.

A sum of 47651994 shares traded at recent session while its average daily volume was at 42.09M shares. T2 Biosystems Inc. shares reached a high of $0.1118 and dropped to a low of $0.0932 until finishing in the latest session at $0.11.

The average equity rating for TTOO stock is currently 2.30, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on T2 Biosystems Inc. [TTOO]:

Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.

The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.01, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 1.14.

TTOO Stock Performance Analysis:

T2 Biosystems Inc. [TTOO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.64. With this latest performance, TTOO shares dropped by -17.19% in over the last four-week period, additionally sinking by -75.96% over the last 6 months – not to mention a drop of -89.50% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 42.89, with the RSI for the last a single of trading hit 44.79, and the three-weeks RSI is set at 42.34 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 0.1294, while it was recorded at 0.1001 for the last single week of trading, and 0.3079 for the last 200 days.

Insight into T2 Biosystems Inc. Fundamentals:

T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.90.

T2 Biosystems Inc. [TTOO] Insider Position Details

There are presently around $2 million, or 5.50% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 9,088,832, which is approximately 80.835% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 2,566,595 shares of the stock with an approximate value of $0.27 million in TTOO stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.16 million in TTOO stock with ownership of nearly -2.697% of the company’s market capitalization.

14 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 4,864,552 shares. Additionally, 29 investors decreased positions by around 1,059,615 shares, while 35 investors held positions by with 13,109,671 shares. The mentioned changes placed institutional holdings at 19,033,838 shares, according to the latest SEC report filing. TTOO stock had 5 new institutional investments in for a total of 215,626 shares, while 11 institutional investors sold positions of 315,610 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here